LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
Will litigation news help to move the AstraZeneca share price?
Investing Articles
Which is the best value stock now: AstraZeneca or GSK?
Investing Articles
Down 14%! Should I buy the dip in the AstraZeneca share price?
Investing Articles
Here’s why a 2023 stock market crash won’t stop me buying bargain shares
Investing Articles
2 relentless UK stocks thrashing the FTSE 100!
Investing Articles
1 FTSE 100 stock I’d buy today and it’s not Lloyds or Rolls-Royce
Investing Articles
I’d ignore gold and start hunting fallen FTSE 100 shares to aim for early retirement
Investing Articles
2 ‘hidden’ AI stocks in the FTSE 100
Investing Articles
Should investors buy AstraZeneca shares after a 16% pullback?
Investing Articles
9 stocks that Fools have been buying!
Investing Articles
2 high-scoring UK quality stocks to consider immediately